‘Taking Advantage of Home-Based Provider Workforce’ Will Be Key to Vaccine Delivery

After nine months of the public health emergency, a major breakthrough took place last week when Pfizer announced that one of its experimental COVID-19 vaccines was more than 90% effective in trials. Similarly promising results from a Moderna vaccine soon followed. Both vaccines still need to be authorized for emergency use by the U.S. Food …

‘Taking Advantage of Home-Based Provider Workforce’ Will Be Key to Vaccine Delivery Read More »